89
Views
3
CrossRef citations to date
0
Altmetric
Theme: Interventional Cardiology - Review

State-of-the-art percutaneous pulmonary valve therapy

&
Pages 589-597 | Published online: 10 Jan 2014

References

  • Bonhoeffer P, Boudjemline Y, Saliba Z et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356 (9239), 1403–1405 (2000).
  • Asoh K, Walsh M, Hickey E et al. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur. Heart J. 31 (11), 1404–1409 (2010).
  • Lurz P, Coats L, Khambadkone S et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 117 (15), 1964–1972 (2008).
  • McElhinney DB, Hellenbrand WE, Zahn EM et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 122 (5), 507–516 (2010).
  • Nordmeyer J, Lurz P, Khambadkone S et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart 97 (2), 118–123 (2011).
  • Khambadkone S, Coats L, Taylor A et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 112 (8), 1189–1197 (2005).
  • Lurz P, Puranik R, Nordmeyer J et al. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur. Heart J. 30 (18), 2266–2274 (2009).
  • Lurz P, Giardini A, Taylor AM et al. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am. J. Cardiol. 105 (5), 721–726 (2010).
  • Plymen CM, Bolger AP, Lurz P et al. Electrical remodeling following percutaneous pulmonary valve implantation. Am. J. Cardiol. 107 (2), 309–314 (2011).
  • Schievano S, Taylor AM, Capelli C et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention 5 (6), 745–750 (2010).
  • Schievano S, Capelli C, Young C et al. Four-dimensional computed tomography: a method of assessing right ventricular outflow tract and pulmonary artery deformations throughout the cardiac cycle. Eur. Radiol. 21 (1), 36–45 (2011).
  • Raikou M, McGuire A, Lurz P, Bonhoeffer P, Wegmueller Y. An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J. Med. Econ. 14 (1), 47–52 (2011).
  • Bonhoeffer P, Boudjemline Y, Saliba Z et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 102 (7), 813–816 (2000).
  • Bonhoeffer P, Boudjemline Y, Qureshi SA et al. Percutaneous insertion of the pulmonary valve. J. Am. Coll. Cardiol. 39 (10), 1664–1669 (2002).
  • Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (6), 842–850 (2006).
  • Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards–Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc. Interv. 67 (5), 659–662 (2006).
  • Leon MB, Smith CR, Mack M et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363 (17), 1597–1607 (2010).
  • Boone RH, Webb JG, Horlick E et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc. Interv. 75 (2), 286–294 (2010).
  • Kenny D, Hijazi ZM, Kar S et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early Phase 1 results from an international multicenter clinical trial. J. Am. Coll. Cardiol. 58 (21), 2248–2256 (2011).
  • Cubeddu RJ, Hijazi ZM. Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valve. Catheter Cardiovasc. Interv. 77 (2), 276–280 (2011).
  • Coats L, Khambadkone S, Derrick G et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 113 (17), 2037–2044 (2006).
  • Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356 (9234), 975–981 (2000).
  • Ovaert C, Caldarone CA, McCrindle BW et al. Endovascular stent implantation for the management of postoperative right ventricular outflow tract obstruction: clinical efficacy. J. Thorac. Cardiovasc. Surg. 118 (5), 886–893 (1999).
  • Oosterhof T, van Straten A, Vliegen HW et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116 (5), 545–551 (2007).
  • Frigiola A, Tsang V, Bull C et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 118 (Suppl. 14), S182–S190 (2008).
  • Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118 (23), e714–e833 (2008).
  • Feltes TF, Bacha E, Beekman RH 3rd et al. American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123 (22), 2607–2652 (2011).
  • Eicken A, Ewert P, Hager A et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur. Heart J. 32 (10), 1260–1265 (2011).
  • Vezmar M, Chaturvedi R, Lee KJ et al. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC Cardiovasc. Interv. 3 (4), 439–448 (2010).
  • Troost E, Meyns B, Daenen W et al. Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration. Eur. Heart J. 28 (20), 2503–2509 (2007).
  • Oosterhof T, Vliegen HW, Meijboom FJ, Zwinderman AH, Bouma B, Mulder BJ. Long-term effect of pulmonary valve replacement on QRS duration in patients with corrected tetralogy of Fallot. Heart 93 (4), 506–509 (2007).
  • Khairy P, Harris L, Landzberg MJ et al. Implantable cardioverter–defibrillators in tetralogy of Fallot. Circulation 117 (3), 363–370 (2008).
  • Broberg CS, Aboulhosn J, Mongeon FP et al.; Alliance for Adult Research in Congenital Cardiology (AARCC). Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am. J. Cardiol. 107 (8), 1215–1220 (2011).
  • Oosterhof T, van Straten A, Vliegen HWet al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116, 545–51 (2007).
  • Tobler D, Crean AM, Redington ANet al. The left heart after pulmonary valve replacement in adults late after tetralogy of Fallot repair. Int. J. Cardiol. (2011) (In press).
  • Simpson KE, Huddleston CB, Foerster S, Nicholas R, Balzer D. Successful subxyphoid hybrid approach for placement of a Melody percutaneous pulmonary valve. Catheter Cardiovasc. Interv. 78 (1), 108–111 (2011).
  • Lurz P, Nordmeyer J, Coats L, Taylor AM, Bonhoeffer P, Schulze-Neick I. Immediate clinical and haemodynamic benefits of restoration of pulmonary valvar competence in patients with pulmonary hypertension. Heart 95 (8), 646–650 (2009).
  • Lurz P, Nordmeyer J, Giardini A et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J. Am. Coll. Cardiol. 57 (6), 724–731 (2011).
  • Gatlin SW, Kim DW, Mahle WT. Cost analysis of percutaneous pulmonary valve replacement. Am. J. Cardiol. 108 (4), 572–574 (2011).
  • Nordmeyer J, Tsang V, Gaudin R et al. Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: impact of in situ homograft geometry on valve competence. Eur. Heart J. 30 (17), 2147–2154 (2009).
  • Schmidt D, Dijkman PE, Driessen-Mol A et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J. Am. Coll. Cardiol. 56 (6), 510–520 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.